Joanna Pownall

T 0883/23: Dosage Claims And Their Entitlement To Priority When Only The Clinical Trial Protocol Was Disclosed In The Priority Application

Polymorphs: Clearing The Inventive Step Hurdle At The European Patent Office (EPO)